Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

antistress aktiengesellschaft für gesundheitsschutz - retinoli palmitas, cholecalciferolum, rrr-alpha-tocopherolum, thiamini nitras, riboflavinum, pyridoxini hydrochloridum, cyanocobalaminum, acidum folicum, biotinum, calcii pantothenas, nicotinamidum, acidum ascorbicum, manganum, zincum, magnesium, ferrum, calcium, phosphorus ruber, selenium, molybdenum, cuprum, factor intrinsicus, acidum 4-aminobenzoicum, inositolum, cholinum - capsule - vitamina: retinoli palmitas 4000 u.i., cholecalciferolum 400 u.i., rrr-a-tocopherolum 33.6 mg, thiamini nitras 3 mg, riboflavinum 3 mg, pyridoxini hydrochloridum 10 mg, cyanocobalaminum 12 µg, acidum folicum 0.4 mg, biotinum 0.3 mg, calcii pantothenas 16.3 mg, nicotinamidum 15 mg, acidum ascorbicum 100 mg, mineralia: manganum 3 mg, zincum 8 mg, magnesium 35 mg, ferrum 5 mg, calcium 70 mg, phosphorus ruber 25 mg, selenium 50 µg, molybdenum 100 µg, cuprum 1 mg, alia: factor intrinsicus 12 µg, acidum 4-aminobenzoicum 15 mg, inositolum 40 mg, ginseng extractum corresp. ginsenosidea 3.4 mg, cholinum (cation) 40 mg, e 321, e 320, arom.: ethylvanillinum, excipiens pro capsula. - tonico per le persone anziane - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pharmaton sa - retinoli palmitas, betacarotenum, cholecalciferolum, int-rac-alfa-tocopherolum, thiamini nitras, riboflavinum, pyridoxini hydrochloridum, cyanocobalaminum, nicotinamidum, acidum folicum, biotinum, acidum ascorbicum, cuprum, calcio, ferro, zincum, magnesio, lysini hydrochloridum - kautabletten - vitamina: retinoli palmitas 715 u. i., betacarotenum 514 µg, cholecalciferolum 150 u. i. int-rac-alfa-tocopherylis acetas 5.22 mg corrisp. int-rac-alfa-tocopherolum 3,5 mg, thiamini nitras 500 µg, riboflavinum 550 µg, pyridoxini hydrochloridum 550 µg, cyanocobalaminum 0.6 µg, nicotinamidum 6 mg, acidum folicum 50 µg, biotinum 15 µg, acidum ascorbicum 22 mg, mineralia: cuprum 300 µg di calcio 65 mg, ferro da 2,5 mg, zincum 2.5 mg, magnesio 12,5 mg, l'altro: lysini hydrochloridum 50 mg, sorbitolum, glucosum monohydricum, arom.: aspartamum, vanillinum e excipiens pro compresso, l'altro. - vitamina - und mineralstoffpräparat - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - retinoli palmitas, cholecalciferolum, int-rac-alpha-tocopherolum, thiaminum, riboflavinum, pyridoxinum, cyanocobalaminum, nicotinamidum, acidum folicum, acidum pantothenicum, biotinum, acidum ascorbicum, calcium, magnesium, ferrum, cuprum, zincum, manganum, iodum, selenium - compresse rivestite con film - vitamina: retinoli palmitas 2566 u. i., cholecalciferolum 200 u. i. int-rac-alfa-tocopherolum 15 mg int-rac-alfa-tocopherylis acetas, thiaminum 1,4 mg per thiamini nitras, riboflavinum 1,4 mg, pyridoxinum 1.9 mg per pyridoxini hydrochloridum, cyanocobalaminum 2.6 µg, nicotinamidum 18 mg, acido-folicum 800 µg di acido d-pantothenicum 6 mg di calcio pantothenas, biotinum 30 µg di acido ascorbicum 85 mg. minerali: calcio 125 mg, magnesio 100 mg, ferro da stiro 60 mg, rame 1 mg, zinco 11 mg, manganum 1.86 mg, iodio 220 µg di selenio 50 mcg. excipiens pro compresso haze. - la vitamina e mineralstoffpräparat per la gravidanza - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

curaden ag - retinolum, cholecalciferolum, (+)-alpha-tocopherolum, thiamini hydrochloridum, riboflavinum, pyridoxini hydrochloridum, cyanocobalaminum, nicotinamidum, acido-folicum, acido d-pantothenicum, biotinum, acido ascorbicum, calcio, ferro, magnesio, rame, zinco, cromo, manganum, molibdeno, potassio, selenio - capsule - vitamina: betacarotenum corresp. retinolum 5000 u.i., cholecalciferolum 200 u.i., (+)-alpha-tocopherolum 30.2 mg, thiamini hydrochloridum 0.8 mg, riboflavinum 1 mg, pyridoxini hydrochloridum 1 mg, cyanocobalaminum 1.5 µg, nicotinamidum 10 mg, acidum folicum 0.2 mg, acidum d-pantothenicum 5 mg ut calcii pantothenas, biotinum 20 µg, acidum ascorbicum 60 mg, mineralia: calcium 26 mg ut calcii hydrogenophosphas dihydricus, ferrum 10 mg ut ferrosi sulfas heptahydricus, magnesium 50 mg ut magnesii oxidum ponderosum, cuprum 1 mg ut cupri sulfas, zincum 7.5 mg ut zinci sulfas monohydricus, chromium 7.5 µg ut chromii(iii) chloridum hexahydricum, manganum 1.2 mg ut mangani(ii) chloridum tetrahydricum, molybdenum 7.5 µg ut natrii molybdas dihydricus, kalium 7.5 mg ut kalii sulfas, selenium 40 µg ut faex siccata cum selenio, alia: ginseng extractum 80 mg corresp. ginsenosidea 4.8 mg, excipiens pro capsula. - roborans - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

streuli pharma ag - chlorhexidini digluconas, retinoli palmitas, iecoris aselli oleum, zinci oxidum - salve - chlorhexidini digluconas 5 mg, retinoli palmitas 400 u.i., iecoris aselli oleum 50 mg, zinci oxidum 50 mg, propylenglycolum, alcoholes adipis lanae, adeps lanae, antiox.: e 320, ethylis gallas, excipiens ad unguentum pro 1 g. - wundsalbe - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

coop vitality health care gmbh - chlorhexidini digluconas, retinoli palmitas, morrhuae olio, zinci oxidum - coop vitality disinfettanti wundsalbe - chlorhexidini digluconas 5 mg, retinoli palmitas 400 u. i., morrhuae olio, 50 mg, zinci oxidum 50 mg, propylenglycolum, alcoli nostro nuovo con, grassi con, antiox.: e 320, ethylis gallas, excipiens annuncio unguento per 1 g. - wundsalbe - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologici - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Unione Europea - italiano - EMA (European Medicines Agency)

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologici - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Unione Europea - italiano - EMA (European Medicines Agency)

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologici - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

fresenius kabi italia srl - retinolo palmitato/ergocalciferolo/tocoferolo alfa/fitomenadione - preparazione iniettabile - "adulti concentrato per emulsione per infusione" 10 fiale 10 ml - vitamins